0 items USD 0.00Search
- Did you mean
- human epidemic
Your search for "Human%20Epidermal" gave back 29476 results.
Highlights The global Human Recombinant Growth Factors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The global Reconstructed Human Full Thickness Skin Model market size is expected to reach $ million by 2029, rising at a market growth of % CAGR...
Catalog:
GIR
December 2023
Price: USD 4,480.00
Oligopeptide-1 (Synthetic Human Epidermal Growth Factor, EGF, Sh-EGF) sh-oligopeptide-1 is the human Epidermal Growth Factor indicated on colon...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
According to our Publisher latest study, the global Human Recombinant Growth Factors market size was valued at USD million in 2022 and is forecast to...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Human Recombinant Growth Factors market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Oligopeptide-1 (Synthetic Human Epidermal Growth Factor, EGF, Sh-EGF) sh-oligopeptide-1 is the human Epidermal Growth Factor indicated on colon...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA...
Catalog:
Global Markets Direct
October 2022
Price: USD 3,500.00
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor. The “Trastuzumab...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Stomach cancer is the fifth most common cancer in the world The global Stomach Cancer and Gastric Cancer Drugs market is projected to reach US$ 9059...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Stomach cancer is the fifth most common cancer in the world The global Stomach Cancer and Gastric Cancer Treatment market is projected to reach US$...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Publisher' newest research report, the “Recombinant Growth Factors Industry Forecast” looks at past sales and reviews total world Recombinant...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor. Highlights The global...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Toll Like Receptor 8 (CD288 or TLR8) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Stomach cancer is the fifth most common cancer in the world The “Stomach Cancer and Gastric Cancer Treatment Industry Forecast” looks at past sales...
Catalog:
LPI
March 2023
Price: USD 3,660.00
